Silence Therapeutics reported $13.61M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
AstraZeneca USD 31.27B 286M Sep/2026
Autolus Therapeutics Ltd USD 98.65M 29.86M Sep/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Novartis USD 32.52B 777M Sep/2026
Roche Holding CHF 28.85B 846M Jun/2026
Silence Therapeutics USD 13.61M 3.77M Dec/2025